We detected no between-group difference in treatment effect on transplant failure during the first 6 months ( 16 [ 4 % ] patients vs 13 [ 3 % ] patients ; HR 123 , 059-255 ; p = 058 ) or serious infection ( 135 [ 32 % ] patients vs 136 [ 32 % ] patients ; HR 102 , 080-129 ; p = 088 ) .